Are Nucleus Software Exports Ltd latest results good or bad?

1 hour ago
share
Share Via
Nucleus Software Exports Ltd's latest results are concerning, showing a significant decline in net sales and profit, with the lowest revenue in eight quarters and increased employee costs impacting profitability. Despite having no long-term debt, the company faces challenges in restoring growth and investor confidence.
Nucleus Software Exports Ltd has reported its financial results for the first quarter of FY27, revealing significant challenges across key operational metrics. The company recorded net sales of ₹210.43 crores, reflecting a quarter-on-quarter decline of 6.38% and a year-on-year decrease of 3.35%. This marks the lowest revenue figure in the last eight quarters, raising concerns about demand dynamics and competitive positioning.
Net profit for the quarter stood at ₹23.87 crores, which represents a substantial quarter-on-quarter decline of 30.91% and a year-on-year drop of 32.19%. The operating profit, excluding other income, fell dramatically to ₹7.96 crores, indicating a 77.23% decline from the previous quarter, resulting in an operating margin of just 3.78%, the lowest in eight quarters. The company's profit after tax margin also contracted to 11.34%, down from 15.37% in the preceding quarter, highlighting the pressures on profitability. A notable factor contributing to these results is the escalation in employee costs, which rose to ₹157.18 crores, now constituting 74.69% of net sales, up from 67.39% in the previous quarter. Despite these operational challenges, Nucleus Software maintains a net cash position with zero long-term debt, providing some financial flexibility. However, the company has seen a decline in institutional investor confidence, with foreign institutional investor holdings decreasing significantly over the past year. Overall, the financial results indicate a concerning trend for Nucleus Software, characterized by deteriorating margins, declining revenues, and operational inefficiencies. The company saw an adjustment in its evaluation, reflecting the challenges it faces in restoring growth and profitability amidst a competitive landscape.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News